
Urs Kientsch
Urs Kientsch is a senior executive at GlaxoSmithKline (GSK), responsible for price negotiations with the Swiss Federal Office of Health (BAG). He has been vocal about the impact of high generic drug prices in Switzerland, suggesting that reducing these costs could free up substantial resources for financing innovative medications.
Power734
Reach9,072
Country presence
Recent news mentions
Urs Kientsch is responsible for price negotiations with the Swiss health authority at GlaxoSmithKline.
Der Schweiz drohen happige AufschlägeNeue Zürcher Zeitung·
Switzerland· 2026-09-21


